Print

Prostate Cancer

Caroline Fairhurst, Ian Watt, Fabiola Martin, Martin Bland, William J Brackenbury

ID
PH460
Version ID
920
Type
Disease or Syndrome
Data Sources
Valid event data range
01/01/1998 - 31/12/2013
Sex
♀  Female ♂  Male
Agreement Date
2014-11-14
Coding system
Read codes v2
Collections
ClinicalCodes Repository Phenotype Library
Tags
No tags

Definition

A cohort study based on primary care data from the QResearch database will include patients with one of the three common tumours: breast, bowel and prostate. The primary outcome will be overall survival from the date of cancer diagnosis. Cox proportional hazards regression will be used to compare the survival of patients with cancer taking VGSC-inhibiting drugs (including anticonvulsants and class I antiarrhythmic agents) with patients with cancer not exposed to these drugs, adjusting for age and sex. Exposure to VGSC-inhibiting drugs will be defined as having at least one prescription for these drugs prior to cancer diagnosis. High and low exposure groups will be identified based on the length of use. A number of sensitivity and secondary analyses will be conducted.

Publications

  • Caroline Fairhurst, Ian Watt, Fabiola Martin, Martin Bland, William J Brackenburry, Exposure to sodium channel-inhibiting drugs and cancer survival protocol for a cohort study using the QResearch primary care database. BMJ Open, 4:e006604 2014.

Clinical Code List

Rows: 18
Code Description Entity type Category Coding System (Read)
14270 H/O: prostate cancer res17: Prostate cancer diagnostic Read
1J08 Suspected prostate cancer res17: Prostate cancer diagnostic Read
4M0 Gleason grading of prostate cancer res17: Prostate cancer diagnostic Read
4M00 Gleason prostate grade 2-4 (low) res17: Prostate cancer diagnostic Read
4M01 Gleason prostate grade 5-7 (medium) res17: Prostate cancer diagnostic Read
4M02 Gleason prostate grade 8-10 (high) res17: Prostate cancer diagnostic Read
B46 Malignant neoplasm of prostate res17: Prostate cancer diagnostic Read
B58y5 Secondary malignant neoplasm of prostate res17: Prostate cancer diagnostic Read
B7C20 Adenoma of prostate res17: Prostate cancer diagnostic Read
B834 Carcinoma in situ of prostate res17: Prostate cancer diagnostic Read
B8340 High grade prostatic intraepithelial neoplasia res17: Prostate cancer diagnostic Read
B8341 Prostatic intraepithelial neoplasia res17: Prostate cancer diagnostic Read
B915 Neoplasm of uncertain behaviour of prostate res17: Prostate cancer diagnostic Read
EMISNQPR140 Prostatic intraepithelial neoplasia res17: Prostate cancer diagnostic Read
HNG0200 [RFC] Cancer of the prostate res17: Prostate cancer diagnostic Read
K223 Dysplasia of prostate res17: Prostate cancer diagnostic Read
PCSDT1PR16 Prostate carcinoma res17: Prostate cancer diagnostic Read
ZV104-5 [V]Personal history of malignant neoplasm of prostate res17: Prostate cancer diagnostic Read

API

To Export Phenotype Details:

Format API
XML site_root/api/v1/public/phenotypes/PH460/version/920/detail/?format=xml
JSON site_root/api/v1/public/phenotypes/PH460/version/920/detail/?format=json
R Package

# Download here

library(ConceptLibraryClient)


# Connect to API

client = connect_to_API(public=TRUE)


# Get details of phenotype

details = get_phenotype_detail_by_version('PH460', '920', api_client=client)

To Export Phenotype Code List:

Format API
XML site_root/api/v1/public/phenotypes/PH460/version/920/export/codes/?format=xml
JSON site_root/api/v1/public/phenotypes/PH460/version/920/export/codes/?format=json
CSV site_root/phenotypes/PH460/version/920/export/codes/
R Package

# Download here

library(ConceptLibraryClient)


# Connect to API

client = connect_to_API(public=TRUE)


# Get codelists of phenotype

codelists = get_phenotype_code_list('PH460', '920', api_client=client)

Version History

Version
ID
Name Owner Publish date
920 Prostate Cancer ieuan.scanlon 2021-10-06 currently shown

Export - export all codes into a csv file/JSON/XML for the current phenotype version.

Print - Print page.